Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

PHASE3CompletedINTERVENTIONAL
Enrollment

373

Participants

Timeline

Start Date

July 29, 2017

Primary Completion Date

June 10, 2019

Study Completion Date

July 8, 2019

Conditions
Infertility
Interventions
DRUG

Follitropin delta

Single daily subcutaneous administration through pre-filled injection pen

DRUG

Follitropin beta

Single daily subcutaneous injection in the abdomen

Trial Locations (17)

Unknown

Yachiyo Hospital, Anjo

Investigational Site 8121, Chiba

Yokota Maternity Hospital, Maebashi

Sophia Ladies Clinic, Sagamihara

Investigational Site 8122, Sendai

Investigational Site 8123, Higashiōsaka-shi

Investigational Site 8120, Osaka

Ladies Clinic Kitahama, Osaka

Investigational Site 8125, Saitama-shi

Investigational Site 8124, Shinjuku-Ku

Akita University Hospital, Akita

Yamashita Ladies' Clinic, Hyōgo

Investigational Site 8126, Saitama

Omiya Ladies Clinic, Saitama

Saint Women's Clinic, Saitama

Women's Clinic Fujimino, Saitama

Tokushima University Hospital, Tokushima

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT03228680 - Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women | Biotech Hunter | Biotech Hunter